S. D. Torre

Survival Following Trimodality Therapy in Patients With Locally Advanced Esophagogastric Adenocarcinoma: Does Only a Complete Pathologic Response Matter?

David R. Jones, S. Sihag, Laura H. Tang, 2020, Annals of surgery.

Pembrolizumab in combination with tocilizumab in high-risk hospitalized patients with COVID-19 (COPERNICO): A randomized proof-of-concept phase II study

J. Pérez-García, A. Llombart-Cussac, A. Alonso-Fernández, 2022, International Journal of Infectious Diseases.